Topics

. He can be reached at nsaraceno@mjhlifesciences.com.

Articles

In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain. 

Grünenthal Obtains Valinor Pharma 

The financial commitment includes a pair of expansion plans occurring in the United States and Europe. 

Cordenpharma Invests $984 Million into Its Peptide Tech Platform

The clinical supply facility undergoes a $25 million expansion, welcoming 32,000 more square feet of temperature-controlled storage.

Catalent Finalizes Schorndorf Plant Development Project

The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.

INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus

The acquisition in the ophthalmology space features a $1.3 billon cash payment, with the potential for an additional $1.7 billion if various milestones are met.

Merck Finalizes EyeBio Purchase

The merger combines the companies under the MedPharma name, creating a topical and transepithelial CDMO in the process. 

MedPharm, Tergus Pharma Join Forces

The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.

UPS Healthcare Financially Commits Over $21.6 Million Toward Cold Chain Fleet

The Stelara biosimilar will be commercialized by Sandoz, and is expected to launch by February 2025 for multiple indications, including for the treatment of adult patients with active psoriatic arthritis.

FDA Approves Pyzchiva for Use in the United States

The deal provides the CDMO with ownership of the Lexington facility, allowing for late-phase and commercial gene therapy development and manufacturing of a branded severe Hemophilia B product. 

 Genezen Purchases uniQure’s Gene Therapy Operations in Massachusetts

Following the evaluation, the company will decide whether it wants to move forward with the IDMO’s automated, end-to-end, cell therapy manufacturing platform. 

Business and Finance